Serum microRNA miR-491-5p/miR-206 Is Correlated with Poor Outcomes/Spontaneous Hemorrhagic Transformation after

Xindi Song1, Junfeng Liu1, Yanan Wang1

  • 1Center of Cerebrovascular Diseases, Department of Neurology, West China Hospital of Sichuan University, Chengdu 610041, China.

Brain Sciences
|August 26, 2022
PubMed
Abstract

Insights

Higher serum miR-491-5p levels are linked to better functional outcomes in acute ischemic stroke (AIS) patients. Conversely, elevated miR-206 levels increase the risk of spontaneous hemorrhagic transformation (HT) after AIS.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • The association between specific microRNAs (miRNAs) and functional outcomes or hemorrhagic transformation (HT) following acute ischemic stroke (AIS) remains unclear.
  • Investigating novel biomarkers for predicting prognosis after AIS is crucial.

Purpose of the Study:

  • To examine the correlation between serum levels of miR-491-5p, miR-206, miR-21-5p, and miR-3123 and functional outcomes in AIS patients.
  • To assess the relationship between these miRNAs and the occurrence of spontaneous HT after AIS.

Main Methods:

  • A retrospective analysis of 215 AIS patients was conducted.
  • Serum levels of four specific miRNAs were measured.
  • Statistical models, including logistic regression and generalized additive models, were employed to analyze correlations.

Main Results:

  • Higher serum miR-491-5p levels were independently associated with reduced risk of poor functional outcomes at one year (OR 0.90, p=0.044).
  • Elevated serum miR-206 levels were independently linked to an increased risk of spontaneous HT (OR 1.64, p=0.016).
  • Non-linear correlations were observed between miR-491-5p and functional outcomes, and miR-206 and spontaneous HT.

Conclusions:

  • Serum miR-491-5p may serve as a potential biomarker for improved functional prognosis in AIS patients.
  • Serum miR-206 could be a predictive biomarker for spontaneous HT risk in AIS.
  • These miRNAs show potential for guiding therapeutic strategies and improving patient outcomes after AIS.